Sorted By Test Name - Mayo Medical Laboratories

MOLUR
89473
in plant materials, molybdenum deficiency is rare in adults with normal, diverse diets. Typical
molybdenum intake in most geographic locations is between 45 mcg/day and 90 mcg/day.(1) Urine is the
primary source of excretion, though excesses are sometimes excreted by the biliary route. Molybdenum
deficiency associated with parenteral nutrition is indicated by symptoms such as stunted growth, reduced
appetite, tachycardia, tachypnea, blindness, and coma. These symptoms can be corrected by introducing
molybdenum supplementation.(3) Molybdenum cofactor disease is a severe genetic disorder that is due to
defective mutations in the MOCS1, MOCS2, and GEPH genes. Molybdenum toxicity is rare and usually
related to molybdenum mining exposure; however it but has been observed in cases of intake >400
mcg/day. Molybdenum interferes with copper uptake; molybdenum toxicity is predominantly due to
copper deficiency (hypochromic anemia and neutropenia) and inhibition of xanthine oxidase (uric acid
accumulation). Urine molybdenum concentrations are likely to be increased above the reference range in
patients with metallic joint prosthesis. Prosthetic devices produced by Zimmer Company and Johnson &
Johnson typically are made of aluminum, vanadium, and titanium. Prosthetic devices produced by Depuy
Company, Dow Corning, Howmedica, LCS, PCA, Osteonics, Richards Company, Tricon, and Whiteside
typically are made of chromium, cobalt, and molybdenum. This list of products is incomplete, and these
products change occasionally; see prosthesis product information for each device for composition
details.(4-5)
Useful For: Monitoring of parenteral nutrition Monitoring metallic prosthetic implant wear As an
indicator of molybdenum cofactor disease
Interpretation: Molybdenum excretion rates are variable and related to dietary intake. Evaluation of
124 healthy adults by Mayo Clinic suggested a reference range of 22 mcg/specimen to 173 mcg/specimen.
Prosthesis wear is known to result in increased circulating concentration of metal ions.(5-6) No increase
in urine molybdenum concentration is evident with a prosthetic device in good condition. Urine
concentrations >200 mcg/specimen in a patient with a molybdenum-based implant suggest significant
prosthesis wear. Increased urine trace element concentrations in the absence of corroborating clinical
information do not independently predict prosthesis wear or failure. Urine molybdenum